Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2025 Earnings Call Transcript May 13, 2025
Y-mAbs Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.22.
Operator: Good morning, and welcome to Y-mAbs Therapeutics First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. Instructions for the question-and-answer session will follow the prepared remarks. As a reminder, today’s conference will be recorded. I...
